There is a saline placebo being used for the first time really in vaccine safety

trials in the pre-licensure phase, which is where we've been because the

informed consent action network, our nonprofit petitioned the FDA. They were

going to be using meningococcal vaccines and things that were being used

around the world and we said the informed consent action network will not allow

you to call this a safety trial. If you do not have a true you know safety

baselines set by a saline placebo and within days we saw them stop down based

retrials and add a saline placebo. So now what are they you know what is it you

want to share about that placebo? Yeah this is in Pfizer's own documents. Now

they're talking about this is the heading called sponsors plans for

continued blinded placebo control follow-up. It says the sponsor Pfizer plans to

offer vaccination to participants equal to or over 16 years of age who

originally received placebo and who become eligible for recipient of BNT 162B2

that's Pfizer shot according to local or national recommendations. The sponsor

also proposes that all placebo recipients equal a greater to 16 years of age

will be offered the shot after completing six months of follow-up after dose

two if they did not request and receive vaccine previously. So they're

unblinded so we're going to basically what this is saying in a lot of words is

after six months we are going to destroy our placebo group we're essentially

going to offer everyone in the placebo group. First of all let them know you

were in the placebo group and start injecting with a vaccine if you want it

therefore I mean here's the news flash right for for the last several years we

...